The Jerusalem Post reported on the approval. The company plans to pivot its effort to earning approval from the Israeli Health Ministry. Once it earns the ministry’s approval, it’ll start marketing the technology in both countries.
The device allows clinicians to insert stents simultaneously to bile ducts connected to the pancreas, which could reduce infection risk.
More articles on surgery centers:
Top-paying jobs in 2020 — Surgeons are No. 1
The state of ASCs in June 2020: 10 observations on supply chain, payers, staffing & future growth
Optum leads $26M funding round for digital therapeutics startup
